Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma
source: pixabay.com

Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma

Based on new data, the European Medicines Agency’s Committee for Medicinal Products for Human Use has designated nivolumab and ipilimumab as the frontline treatment for malignant pleural mesothelioma (MPM) in…

Continue Reading Nivolumab and Ipilimumab as a Treatment for Malignant Pleural Mesothelioma
A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA
qimono / Pixabay

A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA

Corticosteroids are used to treat a wide variety of inflammatory conditions, with asthma and arthritis acting as examples. However, these drugs can result in a variety of side effects, such…

Continue Reading A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA